decisionhealth Newsletters, Part B News - 2003 Issue 9 (September)
Your payments for drugs would change under proposed rule
Subscribe or sign in to view the full article.
Article Overview
This article reviews a 2003 CMS proposed rule addressing how Medicare pays for drugs administered in physician offices, with attention to possible shifts in payment policy and the concerns raised by specialty groups. It is relevant to physicians, practice administrators, oncology stakeholders, and other office-based specialties affected by Medicare drug reimbursement and practice expense payment changes. The discussion also places the proposal in the context of related congressional Medicare reform efforts and CMS comment timelines.
Why This Topic Matters
Changes to Medicare drug payment methodology can affect practice revenue, office operations, and the distribution of funds between drug reimbursement and practice expense payments. The article helps readers understand why specialty societies were monitoring the proposal and how CMS framed the potential budget impact.
What You Will Learn
- What CMS proposed regarding Medicare drug payment policy
- Which broad payment methods were being considered
- Why specialty societies and oncology practices were paying close attention
- How the proposal related to broader Medicare reform discussions
- Why non-billing practices might still be affected by drug reimbursement changes
Who Should Read This
- Physicians
- Oncology practice administrators
- Specialty society staff
- Medical practice managers
- Healthcare policy analysts
- Medical coders involved in Medicare reimbursement topics
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com